Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structure supports the design of inhibitors targeting specific enzymes and receptors, making it valuable in drug discovery for neurological and psychiatric disorders. The fluorophenyl and cyclopropane moieties enhance metabolic stability and binding selectivity, which are beneficial traits in optimizing pharmacokinetic profiles of new drug candidates.